Literature DB >> 10739643

Cyclosporin ameliorates traumatic brain-injury-induced alterations of hippocampal synaptic plasticity.

B C Albensi1, P G Sullivan, M B Thompson, S W Scheff, M P Mattson.   

Abstract

Although traumatic brain injury (TBI) often results in impaired learning and memory functions, the underlying mechanisms are unknown and there are currently no treatments that can preserve such functions. We studied plasticity at CA3-CA1 synapses in hippocampal slices from rats subjected to controlled cortical impact TBI. Long-term potentiation (LTP) of synaptic transmission was markedly impaired, whereas long-term depression (LTD) was enhanced, 48 h following TBI when compared to unoperated and sham control rats. Post-TBI administration of cyclosporin A, a compound that stabilizes mitochondrial function, resulted in a highly significant amelioration of the impairment of LTP and completely prevented the enhancement of LTD. Our data suggest that alterations in hippocampal synaptic plasticity may be responsible for learning and memory deficits resulting from TBI and that agents such as cyclosporin A that stabilize mitochondrial function may be effective treatments for TBI. Copyright 2000 Academic Press.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10739643     DOI: 10.1006/exnr.1999.7338

Source DB:  PubMed          Journal:  Exp Neurol        ISSN: 0014-4886            Impact factor:   5.330


  35 in total

Review 1.  Excitotoxic and excitoprotective mechanisms: abundant targets for the prevention and treatment of neurodegenerative disorders.

Authors:  Mark P Mattson
Journal:  Neuromolecular Med       Date:  2003       Impact factor: 3.843

Review 2.  Mitochondrial regulation of neuronal plasticity.

Authors:  Mark P Mattson
Journal:  Neurochem Res       Date:  2006-10-06       Impact factor: 3.996

3.  Incretin Mimetics as Rational Candidates for the Treatment of Traumatic Brain Injury.

Authors:  Elliot J Glotfelty; Thomas Delgado; Luis B Tovar-Y-Romo; Yu Luo; Barry Hoffer; Lars Olson; Tobias Karlsson; Mark P Mattson; Brandon Harvey; David Tweedie; Yazhou Li; Nigel H Greig
Journal:  ACS Pharmacol Transl Sci       Date:  2019-02-11

4.  The effects of cyclosporin-A on axonal conduction deficits following traumatic brain injury in adult rats.

Authors:  Beverly S Colley; Linda L Phillips; Thomas M Reeves
Journal:  Exp Neurol       Date:  2010-04-01       Impact factor: 5.330

5.  The mitochondrial permeability transition pore provides a key to the diagnosis and treatment of traumatic brain injury.

Authors:  Richard L Veech; C Robert Valeri; Theodore B VanItallie
Journal:  IUBMB Life       Date:  2012-02       Impact factor: 3.885

6.  Decoding hippocampal signaling deficits after traumatic brain injury.

Authors:  Coleen M Atkins
Journal:  Transl Stroke Res       Date:  2011-12       Impact factor: 6.829

7.  Recovery of afferent function and synaptic strength in hippocampal CA1 following traumatic brain injury.

Authors:  Christopher M Norris; Stephen W Scheff
Journal:  J Neurotrauma       Date:  2009-12       Impact factor: 5.269

8.  The interplay between mitochondrial complex I, dopamine and Sp1 in schizophrenia.

Authors:  Dorit Ben-Shachar
Journal:  J Neural Transm (Vienna)       Date:  2009-11       Impact factor: 3.575

9.  Dosing and safety of cyclosporine in patients with severe brain injury.

Authors:  Jimmi Hatton; Bonnie Rosbolt; Philip Empey; Richard Kryscio; Byron Young
Journal:  J Neurosurg       Date:  2008-10       Impact factor: 5.115

Review 10.  Mitochondria in traumatic brain injury and mitochondrial-targeted multipotential therapeutic strategies.

Authors:  Gang Cheng; Rong-hua Kong; Lei-ming Zhang; Jian-ning Zhang
Journal:  Br J Pharmacol       Date:  2012-10       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.